ANI Pharma (ANIP) Launches Nitazoxanide Tablets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
March 19, 2025 6:50 AM EDTPRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANIs Nitazoxanide Tablets are the generic version of the reference listed drug (RLD) Alinia®.
"The market launch of Nitazoxanide Tablets, another niche limited competition product, underscores our purpose of Serving Patients, Improving Lives, stated Nikhil Lalwani, President and Chief Executive Officer of ANI.
"We share ANIs commitment to providing affordable, high-quality medicines for the patients who depend on them and are... More
